OncoGenex Pharma (OGXI) Tops Q1 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. FMC
10. MRSH

Go back to OncoGenex Pharma (OGXI) Tops Q1 EPS by 14c

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2015

May 14, 2015 4:01 PM EDT

Conference call to be held on Thursday, May 14, 2015 at 4:30 p.m. Eastern Time

BOTHELL, Wash. and VANCOUVER, British Columbia, May 14, 2015 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced first quarter 2015 financial results.

Recent Developments and Anticipated Near-term Milestones

Custirsen

On April 27, 2015 OncoGenex announced it regained rights to custirsen, its investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers. This transfer of rights occurred in connection with the termination of the 2009... More